Reynoso Jamie L.'s Form 4 filing
Clover Health Investments, Corp. (CLOV) · filed Jul 8, 2025
- Accession no.
- 0001801170-25-000168
- Filed
- Jul 8, 2025
- Trade date
- Jul 3-7, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $56.8K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Reynoso Jamie L.CIK 0001839066 | Officer (CEO, Medicare Advantage) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | Class A Common Stock | SSaleDisposed | −19,789 | $2.58 | −$51,055.62 | 3,308,539 | Direct | |
| Jul 3, 2025 | Class A Common Stock | FTax withholdingDisposed | −8,706 | $2.56 | −$22,287.36 | 3,299,833 | Direct | |
| Jul 7, 2025 | Class A Common Stock | SSaleDisposed | −2,012 | $2.85 | −$5,734.2 | 3,297,821 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.